About
I’m a data science and computational biology executive with 15+ years of experience building and leading cross-functional data science, machine learning, and computational biology teams — most recently as VP, Head of Data Sciences at Neumora Therapeutics. I translate between data science, life sciences, and clinical sciences to maximize the impact of drug discovery and development programs, from early target discovery through Phase 3 clinical trials.
I’m currently exploring new full-time leadership roles in biotech and pharma, and taking on a limited number of fractional and advisory engagements.
Consulting
Fractional / interim leadership
Embedded, part-time Head/VP of Data Science for biotech companies that need senior leadership without a full-time hire.
Hourly advisory
Strategy sessions and technical review on data science, computational biology, and team-building questions.
Project-based engagements
Scoped projects such as a data science org build-out plan, computational pipeline audit, or genomics data strategy.
Expertise
Experience
VP, Head of Data Sciences — Neumora Therapeutics
2020–2026
Led a cross-functional data science, ML, and computational biology team spanning the full drug discovery/development pipeline, from target discovery through Phase 3 neuropsychiatric and neurodegenerative trials. Co-inventor on multiple clinical ML and therapeutic-use patents. Developed fit-for-purpose development strategies to enhance drug response and reduce placebo response using wide array of data modalities.
Group Leader, Data Science & Lead Investigator — Lieber Institute for Brain Development
2013–2020
Built and led a lab of 10+ scientists studying the genomics of brain development and severe mental illness. Principal Investigator on 10 NIH grants totaling $20M+. Published 145+ research articles (H-index 65).
Professor (Adjunct) — Johns Hopkins University
2013–Present
Departments of Psychiatry & Behavioral Sciences and Neuroscience
Education
- PhD, Epidemiology (Human Genetics/Genetic Epidemiology) — Johns Hopkins Bloomberg School of Public Health, 2011
- MHS, Bioinformatics — Johns Hopkins Bloomberg School of Public Health, 2011
Publications
145+ peer-reviewed research articles, an H-index of 69, and recognition as a Highly Cited Researcher (top 1% of research, 2018). Full list on Google Scholar.